Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Tofogliflozin on Urine Albumin-to-Creatinine Ratio Compared to Metformin Hydrochloride in Diabetic Kidney Disease

NCT05469659 is registered in ClinicalTrials.gov with Shinshu University as lead sponsor.

NCT NCT05469659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05469659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Tofogliflozin on Urine Albumin-to-Creatinine Ratio Compared to Metformin Hydrochloride in Diabetic Kidney Disease
Lead sponsor
Shinshu University
Phase
Phase 2
Overall status
Recruiting
Start date
September 22, 2021
Completion date
October 30, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metformin, sglt2-inhibitors, t2dm (type 2 diabetes mellitus)